World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
30041
World Ranking
11343
National Ranking
5821

Garth Powis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Garth Powis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 494 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Garth Powis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Garth Powis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Garth Powis is affiliated with the Discovery Institute in the United States and focuses research in the fields of biochemistry, genetics, molecular biology, and medicine. Their work encompasses several subfields including molecular biology, cell biology, oncology, physiology, and immunology. The body of research is particularly concentrated on topics such as cellular transport and secretion, erythrocyte function and pathophysiology, protein kinase regulation and GTPase signaling, chemokine receptors and signaling, immunotherapy and immune responses, chronic lymphocytic leukemia research, and PI3K/AKT/mTOR signaling in cancer.

Recent publications by Powis include:

  • Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease, 2023, Biomedicine & Pharmacotherapy
  • Structural basis for the association of PLEKHA7 with membrane-embedded phosphatidylinositol lipids, 2021, Structure
  • Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models, 2020, UNC Libraries
  • PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer, 2021, Experimental Cell Research
  • A Robust and Cost-Effective Luminescent-Based High-Throughput Assay for Fructose-1,6-Bisphosphate Aldolase A, 2020, SLAS DISCOVERY

Powis often collaborates with several frequent coauthors, including:

  • Alexander E. Aleshin
  • Yong Yao
  • Laurie A. Bankston
  • Robert Liddington
  • Francesca M. Marassi

Publications are distributed across a range of scientific venues such as Biomedicine & Pharmacotherapy, Structure, UNC Libraries, Experimental Cell Research, and SLAS DISCOVERY.

Best Publications

  • Properties and Biological Activities of Thioredoxins

    Garth Powis;William R Montfort

  • Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.

    Scott Kopetz;Jayesh Desai;Emily Chan;Joel Randolph Hecht

  • Free radical formation by antitumor quinones

    Garth Powis

  • Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

    Nathan T. Ihle;Lauren Averett Byers;Edward S. Kim;Pierre Saintigny

  • The Redox Protein Thioredoxin-1 (Trx-1) Increases Hypoxia-inducible Factor 1α Protein Expression: Trx-1 Overexpression Results in Increased Vascular Endothelial Growth Factor Production and Enhanced Tumor Angiogenesis

    Sarah J. Welsh;William T. Bellamy;Margaret M. Briehl;Garth Powis

  • Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.

    Margareta Berggren;Alfred Gallegos;John R. Gasdaska;Pamela Y. Gasdaska

  • Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling.

    Nathan T Ihle;Ryan Williams;Sherry Chow;Wade Chew

  • Hypoxia inducible factor-1α as a cancer drug target

    Garth Powis;Lynn Kirkpatrick

  • Metabolism and reactions of quinoid anticancer agents

    Garth Powis

  • Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α

    Sarah Welsh;Ryan Williams;Lynn Kirkpatrick;Gillian Paine-Murrieta

  • Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1α

    Mei Yee Koh;Taly Spivak-Kroizman;Sara Venturini;Sarah Welsh

  • The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation.

    Sarah J. Welsh;Ryan R. Williams;Anne Birmingham;David J. Newman

  • Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo

    Amanda Baker;Claire M. Payne;Margaret M. Briehl;Garth Powis

  • Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.

    G Powis;M J Seewald;C Gratas;D Melder

  • Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance

    Nathan T. Ihle;Robert Lemos;Peter Wipf;Adly Yacoub

  • Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

    Muling Mao;Feng Tian;John M. Mariadason;Chun C. Tsao

  • Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues

    A. F. Howie;L. M. Forrester;M. J. Glancey;J. J. Schlager

  • Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival.

    Jennifer Raffel;Achyut K. Bhattacharyya;Alfred Gallegos;Haiyan Cui

  • Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis.

    Larisa Nonn;Margareta Berggren;Garth Powis

  • Cloning and sequencing of a human thioredoxin reductase

    Pamela Y. Gasdaska;John R. Gasdaska;Shawn Cochran;Garth Powis

Frequent Co-Authors

Lars Engman
Lars Engman Uppsala University
Scott Kopetz
Scott Kopetz The University of Texas MD Anderson Cancer Center
Robert C. Liddington
Robert C. Liddington Discovery Institute
Robert T. Abraham
Robert T. Abraham Pfizer (United States)
Moses Rodriguez
Moses Rodriguez Mayo Clinic
William R. Montfort
William R. Montfort University of Arizona
Peter Wipf
Peter Wipf University of Pittsburgh
Hyun Cheol Chung
Hyun Cheol Chung Yonsei University
Han Liang
Han Liang The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn’t always mean taking the traditional path to become a doctor. There are several related online degrees and healthcare career pathways that offer flexibility, affordability, and opportunities for advancement.

For those seeking doctoral-level nursing training at a lower cost, several cheapest dnp online programs provide advanced practice preparation, often fully online. Pharmacists may wish to explore the cheapest online pharmacy school options to save on tuition while earning their credentials.

If you’re planning ahead or supporting a high schooler interested in healthcare, check out some of the best online schools for high school students focused on health information management. Alternatively, for those wanting to quickly enter the workforce, many medical billing and coding classes online offer fast-track options into administrative healthcare roles.

No matter your background or goals, these online programs and career paths make it easier than ever to join the medical field and make a real impact.

Best Scientists Citing Garth Powis

Trending Scientists

Recently Published Articles